These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4075308)

  • 21. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment.
    Levy F
    Aust N Z J Psychiatry; 2002 Aug; 36(4):477-9. PubMed ID: 12169142
    [No Abstract]   [Full Text] [Related]  

  • 22. Desipramine in the treatment of attention deficit disorder in adolescents.
    Gastfriend DR; Biederman J; Jellinek MS
    Psychopharmacol Bull; 1985; 21(1):144-5. PubMed ID: 3983334
    [No Abstract]   [Full Text] [Related]  

  • 23. Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.
    Cak HT; Cetin FC
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):803-4. PubMed ID: 17201625
    [No Abstract]   [Full Text] [Related]  

  • 24. An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder.
    Stein MT; Shafer MA; Elliott GR; Levine S
    J Dev Behav Pediatr; 2001 Apr; 22(2 Suppl):S175-9. PubMed ID: 11332803
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug therapy in attention-deficit hyperactivity disorder.
    Kessler S
    South Med J; 1996 Jan; 89(1):33-8. PubMed ID: 8545689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention deficit disorder.
    Levy F
    Aust N Z J Psychiatry; 1994 Dec; 28(4):693. PubMed ID: 7794215
    [No Abstract]   [Full Text] [Related]  

  • 27. Attention-deficit hyperactivity disorder. The psychostimulants and beyond.
    Ludwikowski K; DeValk M
    Adv Nurse Pract; 1998 Feb; 6(2):55-6, 59-60. PubMed ID: 9555283
    [No Abstract]   [Full Text] [Related]  

  • 28. Desipramine in the treatment of adolescents with attention deficit disorder.
    Gastfriend DR; Biederman J; Jellinek MS
    Am J Psychiatry; 1984 Jul; 141(7):906-8. PubMed ID: 6375400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parental happiness and strain among young adult parents diagnosed with Attention Deficit Hyperactivity Disorder.
    Kroeger RA
    Chronic Illn; 2018 Mar; 14(1):69-75. PubMed ID: 29226701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonidine in attention deficit hyperactivity disorder.
    Hart-Santora D; Hart LL
    Ann Pharmacother; 1992 Jan; 26(1):37-9. PubMed ID: 1606344
    [No Abstract]   [Full Text] [Related]  

  • 31. Attention-deficit disorder: monitored data-based assessment and treatment.
    Yellin AM; Greenberg LM
    Minn Med; 1981 Aug; 64(8):487-90. PubMed ID: 7290045
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features.
    Klorman R; Brumaghim JT; Salzman LF; Strauss J; Borgstedt AD; McBride MC; Loeb S
    Psychopharmacol Bull; 1989; 25(1):109-13. PubMed ID: 2772109
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of tyrosine on attention deficit disorder with hyperactivity.
    Eisenberg J; Asnis GM; van Praag HM; Vela RM
    J Clin Psychiatry; 1988 May; 49(5):193-5. PubMed ID: 3284877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attention deficit disorders with hyperactivity in adulthood; implications for diagnosis and treatment].
    Kooij JJ; Goekoop JG; Gunning WB
    Ned Tijdschr Geneeskd; 1996 Sep; 140(37):1848-51. PubMed ID: 8927155
    [No Abstract]   [Full Text] [Related]  

  • 35. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ADHD with fluoxetine: a preliminary trial.
    Barrickman L; Noyes R; Kuperman S; Schumacher E; Verda M
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):762-7. PubMed ID: 1938791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antidepressive treatment with nortriptyline].
    Escande M; Gayral L; Roux G; Oulès J; Bacciochi M
    Ann Med Psychol (Paris); 1975 Jul; 2(2):393-8. PubMed ID: 1233907
    [No Abstract]   [Full Text] [Related]  

  • 38. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenting experiences of living with a child with attention deficit hyperactivity disorder: a systematic review of qualitative evidence.
    Laugesen B; Groenkjaer M
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):169-234. PubMed ID: 26657468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emotional dysregulation in a child with attention-deficit/hyperactivity disorder and anxiety: psychopharmacological stategies.
    Srivastava A; Coffey B
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):590-3. PubMed ID: 25514544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.